Tactile Medical expects 8%-11% revenue growth in 2026 while expanding integrated lymphedema solutions

Q4 2025 Management View CEO Sheri Dodd highlighted 2025 as a pivotal year, stating that "Through disciplined execution across ...
Seeking Alpha

Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy

MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the ...

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2025 earnings call transcript

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Q4 2025 Earnings Call Transcript February 18, 2026 Operator: Welcome, ladies and gentlemen, to the Fourth Quarter and Full Year 2025 Earnings Conference ...

Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio

Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic ...
Business Insider

Tactile Medical Announces Positive Clinical Trial Results in Lymphedema Patients Using Advanced Pneumatic Compression Device Therapy

MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...